Phase I/II trial of ischemia tolerant mesenchymal stem cells in patients with chronic heart failure.

Trial Profile

Phase I/II trial of ischemia tolerant mesenchymal stem cells in patients with chronic heart failure.

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 13 May 2014

At a glance

  • Drugs Ischemia-tolerant mesenchymal stem cells (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Sponsors Stemedica Cell Technologies
  • Most Recent Events

    • 13 May 2014 New trial record
    • 29 May 2012 Mexico's regulatory agency, COFEPRIS, has approved the protocol of this trial, according to a Stemedica Cell Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top